small molecule

MULTRYS

CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE

Loss of exclusivityJuly 2041latest FDA-listed patent expiry
CompanyAMERICAN REGENT INC

Drug detail

Brand nameMULTRYS
Active ingredientCUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE
StrengthEQ 60MCG COPPER/ML;EQ 3MCG BASE/ML;EQ 6MCG SELENIUM/ML;EQ 1000MCG BASE/ML (1ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJune 2021
Marketing statusRX

Listed patents

PatentExpiresType
12150957July 2041use U-3900
12150956July 2041use U-3900
11975022July 2041use U-3900
11786548July 2041product
11998565July 2041product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

MULTRYS patent cliff — loss of exclusivity July 2041 | CliffBio